Got Period Pain or Cramps? What To Eat and Avoid According To Science

Sora Shimazaki/Pexels

Painful periods are common. More than half of people who menstruate have some pain for up to three days a month, typically throbbing or cramping in the lower abdomen. Digestive changes – such as vomiting, gas, bloating, diarrhoea and a “bubbling gut” – are also common around the time of menstruation.

There are many treatments for period pain (known medically as dysmenorrhoea). Not all these treatments are well-tolerated or work for everyone. We’re learning more about food’s role in influencing inflammation in our body. So, could eating or avoiding certain foods help with painful periods? Here’s what we know based on high-quality research…..Story continues….

By: Lauren Ball , Emily Burch & Pui Ting Wong

Source: Got period pain or cramps? What to eat and avoid, according to science

.

Critics:

Dysmenorrhea, also known as period pain, painful periods or menstrual cramps, is pain during menstruation. Its usual onset occurs around the time that menstruation begins. Symptoms typically last less than three days.The pain is usually in the pelvis or lower abdomen. Other symptoms may include back pain, diarrhea or nausea. Dysmenorrhea can occur without an underlying problem. 

Underlying issues that can cause dysmenorrhea include uterine fibroids, adenomyosis, and most commonly, endometriosis. It is more common among those with heavy periods, irregular periods, those whose periods started before twelve years of age and those who have a low body weight.A pelvic exam and ultrasound in individuals who are sexually active may be useful for diagnosis. Conditions that should be ruled out include ectopic pregnancy, pelvic inflammatory disease, interstitial cystitis and chronic pelvic pain.

Dysmenorrhea occurs less often in those who exercise regularly and those who have children early in life. Treatment may include the use of a heating pad. Medications that may help include NSAIDs such as ibuprofen, hormonal birth control and the IUD with progestogen. Taking vitamin B1 or magnesium may help. Evidence for yoga, acupuncture and massage is insufficient.Surgery may be useful if certain underlying problems are present.

Estimates of the percentage of female adolescents, and women of reproductive age affected are between 50% and 90%.It is the most common menstrual disorder. Typically, it starts within a year of the first menstrual period. When there is no underlying cause, often the pain improves with age or following having a child. The main symptom of dysmenorrhea is pain concentrated in the lower abdomen or pelvis.

It is also commonly felt in the right or left side of the abdomen. It may radiate to the thighs and lower back. Symptoms often co-occurring with menstrual pain include nausea and vomiting, diarrhea, headache, dizziness, disorientation, fainting and fatigue. Symptoms of dysmenorrhea often begin immediately after ovulation and can last until the end of menstruation. This is because dysmenorrhea is often associated with changes in hormonal levels in the body that occur with ovulation.

In particular, prostaglandins induce abdominal contractions that can cause pain and gastrointestinal symptoms. The use of certain types of birth control pills can prevent the symptoms of dysmenorrhea because they stop ovulation from occurring. Dysmenorrhea is associated with increased pain sensitivity and heavy menstrual bleeding.

For many women, primary dysmenorrhea gradually subsides in late second generation. Pregnancy has also been demonstrated to lessen the severity of dysmenorrhea, when menstruation resumes. However, dysmenorrhea can continue until menopause. 5–15% of women with dysmenorrhea experience symptoms severe enough to interfere with daily activities.

There are two types of dysmenorrhea, primary and secondary, based on the absence or presence of an underlying cause. Primary dysmenorrhea occurs without an associated underlying condition, while secondary dysmenorrhea has a specific underlying cause, typically a condition that affects the uterus or other reproductive organs.

prostaglandins released from the uterus. Prostaglandins cause the uterine muscles to tighten and relax causing the menstrual cramps. This type of dysmenorrhea is called primary dysmenorrhea. Primary dysmenorrhea usually begins in the teens soon after the first period. Secondary dysmenorrhea is the type of dysmenorrhea caused by another condition such as endometriosis, uterine fibroids, uterine adenomyosis, and polycystic ovary syndrome. Rarely, birth defects, intrauterine devices, certain cancers, and pelvic infections cause secondary dysmenorrhea.

 If the pain occurs between menstrual periods, lasts longer than the first few days of the period, or is not adequately relieved by the use of nonsteroidal anti-inflammatory drugs (NSAIDs) or hormonal contraceptives, this could indicate another condition causing secondary dysmenorrhea. Membranous dysmenorrhea is a type of secondary dysmenorrhea in which the entire lining of the uterus is shed all at once rather than over the course of several days as is typical.

 

Signs and symptoms include spotting, bleeding, abdominal pain, and menstrual cramps. The resulting uterine tissue is called a decidual cast and must be passed through the cervix and vagina.It typically takes the shape of the uterus itself. Membranous dysmenorrhea is extremely rare and there are very few reported cases. The underlying cause is unknown, though some evidence suggests it may be associated with ectopic pregnancy or the use of hormonal contraception.

When laparoscopy is used for diagnosis, the most common cause of dysmenorrhea is endometriosis, in approximately 70% of adolescents.Other causes of secondary dysmenorrhea include leiomyoma, adenomyosis,ovarian cysts, pelvic congestion, and cavitated and accessory uterine mass. Genetic factors, stress and depression are risk factors for dysmenorrhea. Risk factors for primary dysmenorrhea include: early age at menarche, long or heavy menstrual periods, smoking, and a family history of dysmenorrhea.

Dysmenorrhea is a highly polygenic and heritable condition. There is strong evidence of familial predisposition and genetic factors increasing susceptibility to dysmenorrhea. There have been multiple polymorphisms and genetic variants in both metabolic genes and genes responsible for immunity which have been associated with the disorder. Three distinct possible phenotypes have been identified for dysmenorrhea which include “multiple severe symptoms”, “mild localized pain”, and “severe localized pain”.

While there are likely differences in genotypes underlying each phenotype, the specific correlating genotypes have not yet been identified. These phenotypes are prevalent at different levels in different population demographics, suggesting different allelic frequencies across populations (in terms of race, ethnicity, and nationality). Polymorphisms in the ESR1 gene have been commonly associated with severe dysmenorrhea.

Variant genotypes in the metabolic genes such as CYP2D6 and GSTM1 have been similarly been correlated with an increased risk of severe menstrual pain, but not with moderate or occasional phentoypes. The occurrence and frequency of secondary dysmenorrhea (SD) has been associated with different alleles and genotypes of those with underlying pathologies, which can affect the pelvic region or other areas of the body.

Individuals with disorders may have genetic mutations related to their diagnoses which produce dysmenorrhea as a symptom of their primary diagnosis. It has been found that those with fibromyalgia who have the ESR1 gene variation Xbal and possess the Xbal AA genotype are more susceptible to experiencing mild to severe menstrual pain resulting from their primary pathology. 

Commonly, genetic mutations which are a hallmark of or associated with specific disorders can produce dysmenorrhea as a symptom which accompanies the primary disorder. The diagnosis of dysmenorrhea is usually made simply on a medical history of menstrual pain that interferes with daily activities. However, there is no universally accepted standard technique for quantifying the severity of menstrual pains.

There are various quantification models, called menstrual symptometrics, that can be used to estimate the severity of menstrual pains as well as correlate them with pain in other parts of the body, menstrual bleeding and degree of interference with daily activities.

Once a diagnosis of dysmenorrhea is made, further workup is required to search for any secondary underlying cause of it, in order to be able to treat it specifically and to avoid the aggravation of a perhaps serious underlying cause. Further work-up includes a specific medical history of symptoms and menstrual cycles and a pelvic examination. Based on results from these, additional exams and tests may be motivated, such as: Gynecologic ultrasonography, Laparoscopy…

“Menstruation and the menstrual cycle fact sheet”. Office of Women’s Health. December 23, 2014. Archived from the original on 26 June 2015. Retrieved 25 June 2015.

^ Jump up to:^a b c d McKenna KA, Fogleman CD (August 2021). “Dysmenorrhea”. Am Fam Physician. 104 (2): 164–170. PMID 34383437.

^ Jump up to:^a b c d “Period Pain”. MedlinePlus. National Library of Medicine. March 1, 2018. Retrieved November 7, 2018.

^ Jump up to:^{a b c d e} “Dysmenorrhea and Endometriosis in the Adolescent”. ACOG. American College of Obstetricians and Gynecologists. 20 November 2018. Retrieved 21 November 2018.

^ “Dysmenorrhea”. www.hopkinsmedicine.org. 13 May 2019. Retrieved 2019-10-04.

^ “Period pain”. nhs.uk. 2017-10-19. Retrieved 2019-10-04.

^ “Using Foods Against Menstrual Pain”. Physicians Committee for Responsible Medicine. Retrieved 2019-10-04.

^ Jump up to:^a b Gomathy N, Dhanasekar KR, Trayambak D, Amirtha R (November 2019). “Supportive therapy for dysmenorrhea: Time to look beyond mefenamic acid in primary care”. Journal of Family Medicine and Primary Care. 8 (11): 3487–3491. doi:10.4103/jfmpc.jfmpc_717_19. PMC 6881953. PMID 31803641.

^ Payne LA, Rapkin AJ, Seidman LC, Zeltzer LK, Tsao JC (2017). “Experimental and procedural pain responses in primary dysmenorrhea: a systematic review”. Journal of Pain Research. 10: 2233–2246. doi:10.2147/JPR.S143512. PMC 5604431. PMID 29066929.

^ Jump up to:^{a b c d [better source needed]}“Dysmenorrhea – Gynecology and Obstetrics”. Merck Manuals Professional Edition. Archived from the original on 10 September 2017.

^ “Period problems | Office on Women’s Health”. www.womenshealth.gov. Retrieved 14 November 2022.

^ Carlson KJ, Eisenstat SA, Ziporyn TD (2004). The New Harvard Guide to Women’s Health. Harvard University Press. p. 479. doi:10.2307/j.ctv1b9f66x. ISBN 978-0-674-01282-0. JSTOR j.ctv1b9f66x.

^ “How to manage a decidual cast, aka shedding your entire uterus lining in one go”. 3 November 2020.

^ “What is a Decidual Cast?”.

^ Janssen EB, Rijkers AC, Hoppenbrouwers K, Meuleman C, D’Hooghe TM (2013). “Prevalence of endometriosis diagnosed by laparoscopy in adolescents with dysmenorrhea or chronic pelvic pain: a systematic review”. Human Reproduction Update. 19 (5): 570–582. doi:10.1093/humupd/dmt016. PMID 23727940.

^ Hilário SG, Bozzini N, Borsari R, Baracat EC (January 2009). “Action of aromatase inhibitor for treatment of uterine leiomyoma in perimenopausal patients”. Fertility and Sterility. 91 (1): 240–243. doi:10.1016/j.fertnstert.2007.11.006. PMID 18249392.

^ Nabeshima H, Murakami T, Nishimoto M, Sugawara N, Sato N (2008). “Successful total laparoscopic cystic adenomyomectomy after unsuccessful open surgery using transtrocar ultrasonographic guiding”. Journal of Minimally Invasive Gynecology. 15 (2): 227–230. doi:10.1016/j.jmig.2007.10.007. PMID 18312998.

^ Hacker, Neville F., J. George Moore, and Joseph C. Gambone. Essentials of Obstetrics and Gynecology, 4th ed. Elsevier Saunders, 2004. ISBN 0-7216-0179-0^{[page needed]}

^ Acién P, Acién M, Fernández F, José Mayol M, Aranda I (November 2010). “The cavitated accessory uterine mass: a Müllerian anomaly in women with an otherwise normal uterus”. Obstetrics and Gynecology. 116 (5): 1101–1109. doi:10.1097/AOG.0b013e3181f7e735. PMID 20966695. S2CID 20532705.^ Ju H, Jones M, Mishra G (2014). “The prevalence and risk factors of dysmenorrhea”. Epidemiologic Reviews. 36: 104–113. doi:10.1093/epirev/mxt009. PMID 24284871.

^ Jump up to:^{a b c d e} Li Z, Chen J, Zhao Y, Wang Y, Xu J, Ji J, et al. (April 2017). “Common variants in ZMIZ1 and near NGF confer risk for primary dysmenorrhoea”. Nature Communications. 8 (1): 14900. Bibcode:2017NatCo…814900L. doi:10.1038/ncomms14900. PMC 5414039. PMID 28447608.

^ Ju H, Jones M, Mishra G (2014-01-01). “The prevalence and risk factors of dysmenorrhea”. Epidemiologic Reviews. 36 (1): 104–113. doi:10.1093/epirev/mxt009. PMID 24284871.

^ Chen CX, Carpenter JS, Ofner S, LaPradd M, Fortenberry JD (January 2021). “Dysmenorrhea Symptom-Based Phenotypes: A Replication and Extension Study”. Nursing Research. 70 (1): 24–33. doi:10.1097/NNR.0000000000000477. PMC 7736149. PMID 32956256.

^ Wu D, Wang X, Chen D, Niu T, Ni J, Liu X, Xu X (November 2000). “Metabolic gene polymorphisms and risk of dysmenorrhea”. Epidemiology. 11 (6): 648–653. doi:10.1097/00001648-200011000-00006. PMID 11055624. S2CID 27774699.

^ Arslan HS, Nursal AF, Inanir A, Karakus N, Yigit S (2021-08-26). “Influence of ESR1 Variants on Clinical Characteristics and Fibromyalgia Syndrome in Turkish Women”. Endocrine, Metabolic & Immune Disorders Drug Targets. 21 (7): 1326–1332. doi:10.2174/1871530320666200910110915. PMID 32914729. S2CID 221623106.

^ Osayande AS, Mehulic S (March 2014). “Diagnosis and initial management of dysmenorrhea”. American Family Physician. 89 (5): 341–346. PMID 24695505.

^ Osonuga A, Ekor M (December 2019). “Risk factors for dysmenorrhea among Ghanaian undergraduate students”. African Health Sciences. 19 (4): 2993–3000. doi:10.4314/ahs.v19i4.20. PMC 7040311. PMID 32127874.

^ Jump up to:^a b Dogru HY, Ozsoy AZ, Karakus N, Delibas IB, Isguder CK, Yigit S (August 2016). “Association of Genetic Polymorphisms in TNF and MIF Gene with the Risk of Primary Dysmenorrhea”. Biochemical Genetics. 54 (4): 457–466. doi:10.1007/s10528-016-9732-2. PMID 27105877. S2CID 86975436.

^ Erten S, Altunoglu A, Keskin HL, Ceylan GG, Yazıcı A, Dalgaci AF, et al. (September 2013). “Increased frequency of MEFV gene mutations in patients with primary dysmenorrhea”. Modern Rheumatology. 23 (5): 959–962. doi:10.3109/s10165-012-0779-6. PMID 23053724. S2CID 75848809.

^ Jump up to:^a b Fenakel K, Lurie S (December 1990). “The use of calcium channel blockers in obstetrics and gynecology; a review”. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 37 (3): 199–203. doi:10.1016/0028-2243(90)90025-v. PMID 2227064.

^ Jump up to:^a b c Harel Z (December 2006). “Dysmenorrhea in adolescents and young adults: etiology and management”. Journal of Pediatric and Adolescent Gynecology. 19 (6): 363–371. doi:10.1016/j.jpag.2006.09.001. PMID 17174824.

^ Bofill Rodriguez M, Lethaby A, Farquhar C (September 2019). “Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding”. The Cochrane Database of Systematic Reviews. 2019 (9): CD000400. doi:10.1002/14651858.CD000400.pub4. PMC 6751587. PMID 31535715.

^ Wright, Jason and Solange Wyatt. The Washington Manual Obstetrics and Gynecology Survival Guide. Lippincott Williams and Wilkins, 2003. ISBN 0-7817-4363-X^{[page needed]}

^ Rosenwaks Z, Seegar-Jones G (October 1980). “Menstrual pain: its origin and pathogenesis”. The Journal of Reproductive Medicine. 25 (4 Suppl): 207–212. PMID 7001019.

^ Jump up to:^a b Wyatt KM, Dimmock PW, Hayes-Gill B, Crowe J, O’Brien PM (July 2002). “Menstrual symptometrics: a simple computer-aided method to quantify menstrual cycle disorders”. Fertility and Sterility. 78 (1): 96–101. doi:10.1016/s0015-0282(02)03161-8. PMID 12095497.

^ Miller L, Notter KM (November 2001). “Menstrual reduction with extended use of combination oral contraceptive pills: randomized controlled trial”. Obstetrics and Gynecology. LWW Journals. 98 (5 Pt 1): 771–778. doi:10.1016/s0029-7844(01)01555-1. PMID 11704167. S2CID 23668483.

^ Marjoribanks J, Ayeleke RO, Farquhar C, Proctor M (July 2015). “Nonsteroidal anti-inflammatory drugs for dysmenorrhoea”. 

The Cochrane Database of Systematic Reviews. 2015 (7): CD001751. doi:10.1002/14651858.CD001751.pub3. PMC 6953236. PMID 26224322.

^ Armour M, Ee CC, Naidoo D, Ayati Z, Chalmers KJ, Steel KA, et al. (September 2019). “Exercise for dysmenorrhoea”. The Cochrane Database of Systematic Reviews. 2019 (9): CD004142. doi:10.1002/14651858.CD004142.pub4. PMC 6753056. PMID 31538328.

Share this:

• Click to Press This! (Opens in new window)
• Click to email a link to a friend (Opens in new window)
• Click to share on Reddit (Opens in new window)
• Click to share on Telegram (Opens in new window)
• Click to share on Stumbleupon (Opens in new window)
• Click to share on Tumblr (Opens in new window)
• Click to share on WhatsApp (Opens in new window)
• More

Customize buttons

Loading…

abdomen acids bloating bubbling common cramps dysmenorrhoea eat fatty gut health inflamation menstruate oysters pain periodpain treatments vomiting

---

Comments

Leave a Reply

Write a comment...

←Previous: Create Unlimited Number of Unique TalkingFaces To Unleashes a Massive Potential Services